Goal, Objectives, Expected Outcomes Consultation on the impact of WHO-endorsed molecular diagnostics on case and treatment outcome definitions for non MDR-TB and MDR-TB Goal, Objectives, Expected Outcomes WHO, Geneva 12–13 May, 2011

Goal Objectives Expected Outcomes To discuss and refine current definitions of cases and treatment outcomes for non MDR-TB and MDR-TB, especially in anticipation of widespread use of Xpert MTB/RIF Objectives To review and propose refinements to current case definitions for non MDR-TB and MDR-TB (Day 1) To review and propose refinements to current definitions of treatment outcomes for non MDR-TB and MDR-TB (Day 2) Expected Outcomes Agreement on a proposed set of case and treatment outcome definitions for non MDR-TB and MDR-TB, and steps required to adopt these definitions, for consideration by WHO's Strategic and Technical Advisory Group for TB (STAG-TB) in June 2011